Opaleye Management Inc.'s Form 4/A amendment
AmendedEton Pharmaceuticals, Inc. (ETON) · filed Jul 17, 2026
- Accession no.
- 0001493152-26-033818
- Filed
- Jul 17, 2026, 7:12 PM ET
- Trade date
- Jul 14, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 16, 2026
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.06M. It was filed 3 days after the trade.
This amendment replaces 0001493152-26-033577 (filed Jul 16, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −15,000 | $37.54 | −$563,146.5 | 2,665,000 | Indirect | |
| Jul 14, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −13,315 | $37.54 | −$499,886.38 | 40,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.